Skip to main content
logo
CV Sciences, Inc. (CVSI)
OTCMKTS · Delayed Price · Currency is USD
0.0310
+0.0010 (3.33%)
Apr 14, 2026, 3:53 PM EST

CV Sciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
13.7915.711616.2120.05
Revenue Growth (YoY)
-12.20%-1.87%-1.24%-19.17%-17.93%
Cost of Revenue
7.048.548.9210.6611.43
Gross Profit
6.757.177.095.558.62
Selling, General & Admin
7.628.429.4913.3720.84
Research & Development
0.120.120.150.311.19
Other Operating Expenses
-0.52--6.17--
Operating Expenses
7.228.543.4713.6822.03
Operating Income
-0.47-1.373.61-8.13-13.41
Interest Expense
-0.52-0.21-0.06-1.54-0.14
Other Non Operating Income (Expenses)
---0.2--
EBT Excluding Unusual Items
-0.99-1.593.35-9.67-13.55
Impairment of Goodwill
-----2.79
Legal Settlements
--0.83---
Other Unusual Items
0.040.01-1.722.95
Pretax Income
-0.95-2.43.1-9.18-15.64
Income Tax Expense
0.01-0.01-0.01-0.05-0.09
Net Income
-0.96-2.393.1-9.13-15.55
Preferred Dividends & Other Adjustments
---0.92-
Net Income to Common
-0.96-2.393.1-10.05-15.55
Shares Outstanding (Basic)
184176154138108
Shares Outstanding (Diluted)
184176154138108
Shares Change (YoY)
4.94%14.05%11.53%28.03%7.91%
EPS (Basic)
-0.01-0.010.02-0.07-0.14
EPS (Diluted)
-0.01-0.010.02-0.07-0.14
Free Cash Flow
-0.52-0.882.25-1.89-7.52
Free Cash Flow Per Share
-0.00-0.010.01-0.01-0.07
Gross Margin
48.97%45.64%44.27%34.25%42.98%
Operating Margin
-3.41%-8.75%22.56%-50.16%-66.90%
Profit Margin
-6.95%-15.24%19.38%-62.04%-77.58%
Free Cash Flow Margin
-3.74%-5.60%14.08%-11.63%-37.51%
EBITDA
-0.28-1.043.85-7.14-12.26
EBITDA Margin
-2.02%-6.62%24.03%-44.04%-61.15%
D&A For EBITDA
0.190.330.240.991.15
EBIT
-0.47-1.373.61-8.13-13.41
EBIT Margin
-3.41%-8.75%22.56%-50.16%-66.90%
Advertising Expenses
0.10.51.11.21.3
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.